MLEC (Moolec Science) Beneish M-Score: -4.89 (As of Jun. 25, 2026)


MLEC Moolec Science SA MLEC
46 GF Score
Price $7.62
GF Value $84.84
Valuation Possible Value Trap
! 9 Warning Signs
View Full Analysis

What is Moolec Science Beneish M-Score?

Moolec Science MLEC -4.80% 46 Beneish M-Score is -4.89 as of Jun. 25, 2026. GuruFocus rates MLEC with a GF Score™ of 46/100 and a GF Value™ of $84.84 (Possible Value Trap). The stock has 9 warning signs investors should review. Among 831 Biotechnology companies, Moolec Science ranks better than 93.14% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -4.89 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Moolec Science's Beneish M-Score or its related term are showing as below:

MLEC' s Beneish M-Score Range Over the Past 10 Years
Min: -8.3   Med: -4.67   Max: 113.14
Current: -4.89

During the past 5 years, the highest Beneish M-Score of Moolec Science was 113.14. The lowest was -8.30. And the median was -4.67.

Moolec Science Beneish M-Score Historical Data

* Premium members only.

The historical data trend for Moolec Science's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Moolec Science Beneish M-Score Chart

Moolec Science Annual Data
Trend Jun21 Jun22 Jun23 Jun24 Jun25
Beneish M-Score
0.00 0.00 0.00 113.14 -4.89

Moolec Science Semi-Annual Data
Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 113.14 -8.30 -4.89 -4.45

MLEC vs RVPH, CDIO, DRMA: Beneish M-Score Comparison

For the Biotechnology subindustry, Moolec Science's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Moolec Science Beneish M-Score vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Moolec Science's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Moolec Science's Beneish M-Score falls into.


MLEC
46GF Score
Moolec Science SA MLEC
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Moolec Science Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Moolec Science for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.1175+0.528 * 1.0201+0.404 * 1.8549+0.892 * 0.7153+0.115 * 0.2291
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1.3211+4.679 * -0.273655-0.327 * 1.8431
=-4.89

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Jun25) TTM:Last Year (Jun24) TTM:
Total Receivables was $19.9 Mil.
Revenue was $333.6 Mil.
Gross Profit was $125.7 Mil.
Total Current Assets was $31.2 Mil.
Total Assets was $204.7 Mil.
Property, Plant and Equipment(Net PPE) was $3.4 Mil.
Depreciation, Depletion and Amortization(DDA) was $22.3 Mil.
Selling, General, & Admin. Expense(SGA) was $88.8 Mil.
Total Current Liabilities was $236.1 Mil.
Long-Term Debt & Capital Lease Obligation was $19.6 Mil.
Net Income was $-111.5 Mil.
Gross Profit was $-59.1 Mil.
Cash Flow from Operations was $3.6 Mil.
 Total Receivables was $237.1 Mil.
Revenue was $466.4 Mil.
Gross Profit was $179.3 Mil.
Total Current Assets was $438.2 Mil.
Total Assets was $949.8 Mil.
Property, Plant and Equipment(Net PPE) was $86.2 Mil.
Depreciation, Depletion and Amortization(DDA) was $21.3 Mil.
Selling, General, & Admin. Expense(SGA) was $94.0 Mil.
Total Current Liabilities was $427.4 Mil.
Long-Term Debt & Capital Lease Obligation was $216.2 Mil.

1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(19.934 / 333.611) / (237.083 / 466.376)
=0.059752 / 0.508352
=0.1175

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(179.312 / 466.376) / (125.741 / 333.611)
=0.384479 / 0.376909
=1.0201

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (31.192 + 3.446) / 204.71) / (1 - (438.207 + 86.214) / 949.837)
=0.830795 / 0.447883
=1.8549

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=333.611 / 466.376
=0.7153

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(21.332 / (21.332 + 86.214)) / (22.253 / (22.253 + 3.446))
=0.198352 / 0.865909
=0.2291

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(88.826 / 333.611) / (93.993 / 466.376)
=0.266256 / 0.201539
=1.3211

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((19.609 + 236.053) / 204.71) / ((216.219 + 427.403) / 949.837)
=1.248898 / 0.677613
=1.8431

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-111.461 - -59.077 - 3.636) / 204.71
=-0.273655

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Moolec Science has a M-score of -4.89 suggests that the company is unlikely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of -4.89 mean?
Moolec Science (MLEC) has a Beneish M-Score of -4.89 as of Jun. 25, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Moolec Science and its competitors. According to the industry distribution chart, Moolec Science ranks #57 out of 831 companies in the Biotechnology industry, placing it in the top 6.9%.
Is Moolec Science's Beneish M-Score too high?
Moolec Science's current Beneish M-Score is -4.89. Based on the distribution chart, Moolec Science ranks #57 out of 831 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Moolec Science has a GF Score™ of 46/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Moolec Science's Beneish M-Score compare to RVPH and CDIO?
According to the Biotechnology industry distribution chart, Moolec Science ranks #57 out of 831 companies for Beneish M-Score. This places Moolec Science in the top 7% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Biotechnology company?
A good Beneish M-Score depends on the Biotechnology industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Moolec Science and its competitors. Moolec Science's current Beneish M-Score is -4.89. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Moolec Science stock overvalued right now?
Based on GuruFocus' analysis, Moolec Science (MLEC) is currently considered Possible Value Trap. The stock's GF Value™ is $84.84, compared to a current price of $7.62 — trading 91% below its estimated fair value. The current Beneish M-Score is -4.89. Moolec Science's overall GF Score™ is 46/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For Moolec Science (MLEC), the current Beneish M-Score is -4.89 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Moolec Science (MLEC) Overvalued in 2026?

Based on GuruFocus' analysis, Moolec Science stock appears to be undervalued. The current stock price of $7.62 is trading 91% below its estimated GF Value™ of $84.84. GuruFocus considers Moolec Science to be Possible Value Trap.

Key valuation signals for MLEC:

  • Beneish M-Score: -4.89
  • GF Value™: $84.84 vs. price of $7.62 (91% below fair value)
  • GF Score™: 46/100 with 9 warning signs

No single metric tells the full story. See the MLEC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Moolec Science Business Description

Address c/o Ogier Global (Cayman) Limited, 89 Nexus Way, Camana Bay, Grand Cayman, CYM, KY1-9009
Moolec Science SA is a science-based ingredient company focused on producing real animal proteins in plants through Molecular Farming, a technology in the alternative protein landscape. Its purpose is to upgrade the taste, nutrition, and affordability of alternative protein products while building a more sustainable and equitable food system. The company has various products in its pipeline, such as; TSP Valorasoy which is a soy protein product to produce vegetable proteins with texture and fibrousness similar to those of meat, Glaso, a safflower oil with high levels of gamma-linolenic acid, SPC2 which is a plant-based chymosin, YEEA1, an extract derived from a novel yeast biomass with specific properties, and others. The company's maximum revenues from operations in Argentina.
46GF Score

Get the complete analysis for MLEC

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$7.62
Price
$84.84
GF Value